ATE399543T1 - Neue synergistische zusammensetzung enthaltend roflumilast und formoterol - Google Patents

Neue synergistische zusammensetzung enthaltend roflumilast und formoterol

Info

Publication number
ATE399543T1
ATE399543T1 AT03767663T AT03767663T ATE399543T1 AT E399543 T1 ATE399543 T1 AT E399543T1 AT 03767663 T AT03767663 T AT 03767663T AT 03767663 T AT03767663 T AT 03767663T AT E399543 T1 ATE399543 T1 AT E399543T1
Authority
AT
Austria
Prior art keywords
formoterol
composition containing
synergistic composition
new synergistic
containing roflumilast
Prior art date
Application number
AT03767663T
Other languages
English (en)
Inventor
Rolf Beume
Daniela Bundschuh
Norbert Kolassa
Degenhard Marx
Christian Weimar
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Application granted granted Critical
Publication of ATE399543T1 publication Critical patent/ATE399543T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT03767663T 2002-11-27 2003-11-26 Neue synergistische zusammensetzung enthaltend roflumilast und formoterol ATE399543T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02026505 2002-11-27

Publications (1)

Publication Number Publication Date
ATE399543T1 true ATE399543T1 (de) 2008-07-15

Family

ID=32338002

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03767663T ATE399543T1 (de) 2002-11-27 2003-11-26 Neue synergistische zusammensetzung enthaltend roflumilast und formoterol

Country Status (31)

Country Link
US (1) US20060142308A1 (de)
EP (1) EP1567139B1 (de)
JP (1) JP2006508994A (de)
KR (1) KR101071798B1 (de)
CN (1) CN100346777C (de)
AT (1) ATE399543T1 (de)
AU (1) AU2003292120B2 (de)
BR (1) BR0316451A (de)
CA (1) CA2506962C (de)
CO (1) CO5690570A2 (de)
CY (1) CY1110369T1 (de)
DE (1) DE60321953D1 (de)
DK (1) DK1567139T3 (de)
EA (1) EA009935B1 (de)
ES (1) ES2309357T3 (de)
HR (1) HRP20050579B1 (de)
IL (1) IL168308A (de)
IS (1) IS2575B (de)
MA (1) MA27539A1 (de)
ME (1) ME00489B (de)
MX (1) MXPA05005437A (de)
NO (1) NO334247B1 (de)
NZ (1) NZ540659A (de)
PL (1) PL216752B1 (de)
PT (1) PT1567139E (de)
RS (1) RS51081B (de)
SI (1) SI1567139T1 (de)
TN (1) TNSN05131A1 (de)
UA (1) UA83018C2 (de)
WO (1) WO2004047829A1 (de)
ZA (1) ZA200503308B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
SI1606261T1 (sl) 2003-03-10 2010-03-31 Nycomed Gmbh Novi postopek za pripravo roflumilasta
US8663694B2 (en) * 2005-03-16 2014-03-04 Takeda Gmbh Taste masked dosage form containing roflumilast
DE102005030733A1 (de) * 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
RS53084B (sr) * 2006-07-05 2014-06-30 Takeda Gmbh Kombinacija inhibitora hmg-coa reduktaze rosuvastatina sa inhibitorom fosfodiesteraze 4, kao što je roflumilast, roflumilast-n-oksid za lečenje inflamatornih plućnih obolenja
WO2013077830A1 (en) * 2011-11-25 2013-05-30 Mahmut Bilgic Synergistilly active combinations of roflumilast and carmoterol
US20130172303A1 (en) * 2012-01-03 2013-07-04 Forest Laboratories Holdings Ltd. Roflumilast compositions for the treatment of copd
DK2948148T3 (da) * 2013-01-28 2020-10-26 Incozen Therapeutics Pvt Ltd Metoder til behandling af autoimmune, åndedræts- og betændelsesforstyrrelser ved inhalation af roflumilast n-oxid
CN104800214A (zh) * 2014-01-27 2015-07-29 成都英诺新科技有限公司 一种罗氟司特吸入气雾剂复方及制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
CN1046939C (zh) * 1993-07-02 1999-12-01 比克·古尔顿·劳姆贝尔格化学公司 氟烷氧基取代的苯甲酰胺类及其制备方法和应用
DE69835594T2 (de) * 1997-02-17 2007-08-16 Altana Pharma Ag Zusammensetzungen zur behandlung von irds oder ards die 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy) benzamid und lungensurfactant enthalten
DK0975347T3 (da) * 1997-02-28 2008-06-16 Nycomed Gmbh Synergistisk kombination af PDE-inhibitorer og adenylatcyclase-agonister eller guanylcyclyseagonister
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
TR200100500T2 (tr) * 1998-08-26 2001-06-21 Smithkline Beecham Corporation Pulmoner hastalıkların tedavisi için terapiler
US6303145B2 (en) * 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
CZ302882B6 (cs) * 1999-08-21 2012-01-04 Nycomed Gmbh Farmaceutický prostredek
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
ATE381537T1 (de) * 2001-03-22 2008-01-15 Glaxo Group Ltd Formanilid-derivative als beta2-adrenorezeptor- agonisten
MY137522A (en) * 2001-04-30 2009-02-27 Glaxo Group Ltd Novel anti-inflammatory androstane derivatives.

Also Published As

Publication number Publication date
ME00489B (me) 2011-10-10
CY1110369T1 (el) 2015-04-29
PL216752B1 (pl) 2014-05-30
HRP20050579A2 (hr) 2006-04-30
DE60321953D1 (de) 2008-08-14
RS51081B (sr) 2010-10-31
HRP20050579B1 (hr) 2014-01-31
RS20050382A (sr) 2007-08-03
CA2506962C (en) 2012-01-03
WO2004047829A8 (en) 2005-06-30
TNSN05131A1 (en) 2007-05-14
CN1713903A (zh) 2005-12-28
US20060142308A1 (en) 2006-06-29
MA27539A1 (fr) 2005-09-01
CO5690570A2 (es) 2006-10-31
CA2506962A1 (en) 2004-06-10
KR101071798B1 (ko) 2011-10-11
UA83018C2 (uk) 2008-06-10
ES2309357T3 (es) 2008-12-16
WO2004047829A1 (en) 2004-06-10
SI1567139T1 (sl) 2008-12-31
CN100346777C (zh) 2007-11-07
AU2003292120A1 (en) 2004-06-18
EA009935B1 (ru) 2008-04-28
ZA200503308B (en) 2006-11-29
BR0316451A (pt) 2005-10-11
IS2575B (is) 2010-02-15
NZ540659A (en) 2007-05-31
EP1567139B1 (de) 2008-07-02
KR20050085104A (ko) 2005-08-29
EP1567139A1 (de) 2005-08-31
HK1081861A1 (en) 2006-05-26
EA200500774A1 (ru) 2005-12-29
NO334247B1 (no) 2014-01-20
NO20052999L (no) 2005-06-17
IS7898A (is) 2005-06-20
PL377732A1 (pl) 2006-02-06
JP2006508994A (ja) 2006-03-16
DK1567139T3 (da) 2008-11-03
PT1567139E (pt) 2008-10-01
AU2003292120B2 (en) 2010-01-21
IL168308A (en) 2010-12-30
MXPA05005437A (es) 2005-08-03

Similar Documents

Publication Publication Date Title
DE60331236D1 (de) Orale zusammensetzungen zur behandlung von diabetes
ATE320800T1 (de) Synergistische kombination von roflumilast und salmeterol
DK1587506T3 (da) Administration af capsaicinoider
MXPA05006670A (es) Administracion de capsaicinoides.
UY28931A1 (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
WO2004043341A3 (en) Treatment for hemorrhagic shock
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
DK1656131T3 (da) Anvendelse af betain til behandling claudicatio intermittens
CY1110368T1 (el) Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη
DK1212072T3 (da) Farmaceutisk præparat omfattende eukalyptus- og orangeolie

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1567139

Country of ref document: EP